Concepedia
Statistics
Publications
7
Citations
212
H-Index
Active since
2021
Affiliations
University Medical Center Freiburg(Current)
University of Freiburg
Heidelberg University
German Cancer Research Center
Stellenbosch University
Felix Kind is an author at University Medical Center Freiburg.
Publications per year
2021–2025
Combining PSMA-PET and PROMISE to re-define disease stage and risk in patients with prostate cancer: a multicentre retrospective study
Madeleine J. Karpinski, Johannes Hüsing, Lennart Möller et al. · The Lancet Oncology · 2024 · 67 citations · Full text
Prognostic Value of Tumor Volume Assessment on PSMA PET After<sup>177</sup>Lu-PSMA Radioligand Therapy Evaluated by PSMA PET/CT Consensus Statement and RECIP 1.0
Felix Kind, Ann-Christin Eder, Cordula A. Jilg et al. · Journal of Nuclear Medicine · 2022 · 29 citations · Full text
Bone marrow impairment during early [177Lu]PSMA-617 radioligand therapy: Haematotoxicity or tumour progression?
Felix Kind, Kerstin Michalski, Elham Yousefzadeh‐Nowshahr et al. · EJNMMI Research · 2022 · 28 citations · Full text
Kidney Doses in <sup>177</sup>Lu-Based Radioligand Therapy in Prostate Cancer: Is Dose Estimation Based on Reduced Dosimetry Measurements Feasible?
Michael Mix, T Renaud, Felix Kind et al. · Journal of Nuclear Medicine · 2021 · 23 citations · Full text
Early PSA Change after [177Lu]PSMA-617 Radioligand Therapy as a Predicator of Biochemical Response and Overall Survival
Felix Kind, Thomas F. Fassbender, Geoffroy Andrieux et al. · Cancers · 2021 · 22 citations · Full text
1–5 of 7